US EditionPublished • loading... • Updated
Cresco Spine Receives FDA 510(k) Clearance for the Spring Distraction System (SDS™) – Ortho Spine News
19-01-2026 Schiedam, The Netherlands – OrthoSpineNews – Cresco Spine today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Spring Distraction System (SDSTM), a dynamic, growth-friendly implant for the treatment of early onset scoliosis. Earlier in its regulatory trajectory, SDSTM received FDA Breakthrough Device Designation. Since the introduction of this program in 2015, fewer than 0.1 percent of all dev
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cresco Spine Receives FDA 510(k) Clearance for the Spring Distraction System (SDS™) – Ortho Spine News
19-01-2026 Schiedam, The Netherlands – OrthoSpineNews – Cresco Spine today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Spring Distraction System (SDSTM), a dynamic, growth-friendly implant for the treatment of early onset scoliosis. Earlier in its regulatory trajectory, SDSTM received FDA Breakthrough Device Designation. Since the introduction of this program in 2015, fewer than 0.1 percent of all dev
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
